CrystalGenomics Inc banner
C

CrystalGenomics Inc
KOSDAQ:083790

Watchlist Manager
CrystalGenomics Inc
KOSDAQ:083790
Watchlist
Price: 1 479 KRW 13.51% Market Closed
Market Cap: ₩113.7B

CrystalGenomics Inc
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

CrystalGenomics Inc
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
C
CrystalGenomics Inc
KOSDAQ:083790
Goodwill
₩11.4B
CAGR 3-Years
78%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Goodwill
₩11.7T
CAGR 3-Years
567%
CAGR 5-Years
422%
CAGR 10-Years
129%
SK Bioscience Co Ltd
KRX:302440
Goodwill
₩57.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
Goodwill
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CrystalGenomics Inc
Glance View

Market Cap
113.7B KRW
Industry
Biotechnology

CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2006-01-06. The firm operates its business through four segments. The Drug Substance Manufacturing segment manufactures and sells drug substances such as anti-inflammatory analgesics, antispasmodics, and asthma treatments. The Finished Drug Manufacturing segment produces and supplies finished drugs such as cephalosporin antibiotics. The Pharmaceutical Research and Development segment is engaged in the provision of clinical trial analysis and technical services, and sales of new drugs. The company also engages in real estate rental business. The Other segment is engaged in the manufacture and sale of hot pats and other household goods.

Intrinsic Value
Not Available

See Also

What is CrystalGenomics Inc's Goodwill?
Goodwill
11.4B KRW

Based on the financial report for Sep 30, 2025, CrystalGenomics Inc's Goodwill amounts to 11.4B KRW.

What is CrystalGenomics Inc's Goodwill growth rate?
Goodwill CAGR 5Y
15%

Over the last year, the Goodwill growth was 88%. The average annual Goodwill growth rates for CrystalGenomics Inc have been 78% over the past three years , 15% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett